Background The role of B cells in the pathogenesis of multiple sclerosis (MS) is a subject of much research. We report a case of a MS patient who presented with subacute diffuse lesions in the limbic system and short-term memory loss. Case presentation A male patient had experienced numbness in the left upper extremity at the age of 17 years, but this disappeared without treatment. At 19 years-of-age, he developed subacute short-term memory loss followed by paralysis and sensory disturbance in the left upper and lower extremities. Magnetic resonance brain fluid-attenuated/T2-weighted imaging showed diffuse high-intensity lesions in the medial parts of both temporal lobes, and spotty multiple lesions in the periventricular and subcortical white matter. Twenty days later, a new lesion was observed around the right putamen, and the temporal lesions had disappeared. A symptomatic cervical lesion with gadolinium enhancement was observed at C3. This lesion involved just one vertebral segment. Cerebrospinal fluid analysis showed no pleocytosis or elevated protein levels, but did show oligoclonal immunoglobulin G bands. No antibodies against aquaporin-4 or myelin oligodendrocyte glycoprotein were detected in the serum, and anti-Nmethyl-D-aspartate receptor was not detected in the cerebrospinal fluid. We diagnosed the patient with MS despite the atypical diffuse lesions in the limbic system and the short-term memory loss. Corticosteroid medication effectively treated the symptoms in his extremities and his impaired memory. Conclusions The present case shows that cortical lesions can occur in MS patients and might be induced by B cell-mediated mechanisms.
Introduction
Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease that predominantly affects the white matter of the central nervous system (CNS). MS has traditionally been considered a T cell-mediated autoimmune disorder, and the role of humoral immunity in the pathogenesis of MS has gained wide research attention. 1 It has been shown that myelin-specific autoantibodies might contribute to demyelination in an experimental autoimmune encephalomyelitis model of MS. 2 Furthermore, oligoclonal bands, which indicate inflammation in the CNS, are present in the majority of MS patients. In the current report, we describe an MS patient who presented with subacute bilateral limbic lesions and short-term-memory loss, which might have been induced by a B cell-mediated mechanism.
Case report
At the age of 17 years, the patient developed numbness in the left upper extremity that disappeared without treatment. At age 19 years, he presented with short-term memory loss, indicated by asking the same questions multiple times. Symptoms progressed over several weeks, and he eventually developed partial paralysis and numbness of the left upper and lower extremities, at which point he was admitted to another hospital. Initial brain fluid-attenuated/T2-weighted imaging showed high-intensity lesions in the medial parts of both temporal lobes (Fig. 1a,b) . The patient also showed multiple lesions in the periventricular and subcortical white matter (Fig. 1c-e) . He was admitted to Tokyo Metropolitan Neurological Hospital, Tokyo, Japan, for expedited evaluation and treatment.
On evaluation at our hospital, a neurological examination revealed mild spastic paraparesis and hypoesthesia, as well as sensory ataxia of the left upper and lower extremities. The patient was conscious and responsive, but presented with mild short-term memory loss. The extent of the disturbance of delayed recall was determined by the Wecheler Memory Scale-Revised. Blood tests showed no increase in inflammatory response, thyroid hormones or autoantibodies associated with vasculitides, including anti-nuclear antibody, anti-dsDNA antibody, anti-neutrophil cytoplasmic antibody and antibodies to Ro/SSA, La/SSB, thyroglobulin or thyroid peroxydase. Cerebrospinal fluid analysis revealed a normal white blood cell count, protein content and myelin basic protein; however, the patient's immunoglobulin G index was elevated (0.90), and oligoclonal bands were detected. Tests for classical onconeural antibodies (Hu, Ri, Ma2, CV2/CMRP5, amphiphysin and Yo) yielded negative results, and we detected no antibodies against myelin-oligodendrocyte glycoprotein or aquaporin-4 in the serum, nor against N-methyl-D-aspartate receptor in the cerebrospinal fluid. Twenty days after the original images were obtained, brain fluid-attenuated/T2-weighted imaging showed that the temporal lesions had disappeared (Fig. 1f) and a new lesion was observed around the right putamen (Fig. 1g) . However, we observed no gadolinium enhancement in the white matter lesions (Fig. 1h) . A T2-weighted sagittal magnetic resonance imaging (MRI) of the cervical spine showed a vertical lesion centered on C3 (Fig. 2a) . Axial MRI showed lesions in the posterior spinal cord (Fig. 2a) , and post-contrast T1-weighted images showed contrast-enhanced lesions at the same sites, as well as a ring-shaped lesion (Fig. 2b) . Epileptic discharges were not noted by electroencephalogram. No tumor markers were detected, nor were any tumors observed by systemic computed tomography. (e) T1-weighted imaging showed that many of these lesions were hypointense. Twenty days later, (f) the temporal lesions had disappeared, and (g) a new lesion was observed around the right putamen, although there was (h) no gadolinium-enhancement in the white matter lesions.
We diagnosed the patient with MS, even though diffuse lesions in the limbic system with short-term memory loss are atypical for this disease. He was treated by three courses of steroid pulse therapy (1000 mg methylpredonisolone/day for 3 days) and oral prednisolone (60 mg/day). He subsequently recovered from partial paralysis and hypoesthesia, and the gadolinium enhancement observed by cervical MRI improved (Fig. 2c) . The patient was discharged on day 27 after admission to our hospital. He received repeated courses of low-dose oral steroid medication, and his memory deficit began to improve 4 months after the onset of symptoms.
Discussion
In the present report, we describe a patient who presented with clinical features and MRI findings typical of MS, but who also showed atypical subacute short-term memory loss and bilateral medial temporal lobe involvement. The patient did not show pleocytosis in the cerebrospinal fluid, electroencephalogram abnormalities or anti-neuronal antibodies, indicating that overlapping limbic encephalitis was not present. 3 It is not certain that T cell-mediated MS causes limbic lesions, but patients might develop other immunity mechanisms, such as humoral immunity, which involve cortical lesions.
The limbic lesions in the present case might have been caused by the involvement of B cells. Experimental models have shown that antibody-mediated mechanisms might play a role in cortical demyelination. 4 Furthermore, B cells can form packed aggregates in the leptomeningeal space covering the cortical surface, 5 and the cortical areas beneath these aggregates can show demyelination and neuronal degeneration, possibly as a result of antibodies diffusing into the brain. 6 Leptomeningeal B-cell aggregates are a common feature of progressive MS, but they have also been noted in early relapsing-remitting MS. 7 In addition, B cell-depleting anti-CD20 antibodies have been shown to be an effective therapy for early MS, substantially reducing the frequency of relapse and lesion load, as well as improving neurological deficiencies. 8 Thus, it has been suggested that involvement of B cells in the cortical region is suggestive of MS, and that this involvement might occur in the early stages of disease.
This involvement of B cells is further supported by two previous case reports describing cortical lesions in MS patients. Coebergh et al. 9 described a patient with acute memory impairment associated with hippocampal and cortical lesions. That patient also showed white matter lesions. Additionally, Kasaaslan et al. 10 reported the case of a patent who was diagnosed with relapsing-remitting MS and who showed acute short-term memory impairment, as well as time/place disorientation. That patient's MRI showed left medial temporal hyperintensity, and no antibodies associated with limbic encephalitis, such as anti-N-methyl-D-aspartate receptor, were detected. These cases and the current case together indicate that acute onset memory impairment with limbic lesions can occur in MS.
There is a possibility that the humoral response might be caused secondary to CNS damage during the course of relapsing-remitting MS. This is supported by a report that children with relapsing MS more often show autoantibodies against a broader range of CNS antigens compared with children with monophasic demyelinating disorders. 11 In the present case and the case described by Kasaaslan et al. 10 , no antibodies for limbic encephalitis were detected. This indicates that the patients in both reports might have developed uncharacterized antibodies, which in turn could have led to cortical lesions induced by CNS damage. Furthermore, both cases did not show any evidence of tumor, suggesting a CNS-induced mechanism.
The present case report suggests that inflammatory cortical lesions can occur in MS patients, and these might be induced by B cell-mediated mechanisms. Unfortunately, the pathogenic mechanisms of MS are not yet fully understood, nor is the role of B cells within MS pathology. Further investigations are required to clarify the diagnosis of MS and to develop new therapeutic approaches.
